Martin Shkreli, the controversial pharmaceutical executive, is facing legal action from the Federal Trade Commission (FTC) and seven US states for allegedly violating a lifetime ban on participating in the pharmaceutical industry. The motion was filed on Tuesday in the US District Court in New York City.
Allegations of Violations
The FTC claims that Shkreli, known as the "Pharma Bro," has traded stocks in at least 60 pharmaceutical companies and made public comments about their businesses since his release from prison in May 2022. His release conditions explicitly prohibit him from any direct or indirect involvement in the pharmaceutical sector, including owning stakes in companies or influencing their business decisions.
The FTC's motion states that Shkreli has used platforms like YouTube, X, and Reddit to publicize his activities. During one livestream, he reportedly stated:
“"I’m showing you how to trade and invest in biotech."
In another instance, he described his trading strategy as a "magic trick," claiming:
“"It doesn’t matter what trades I make because I can always find a couple of biotech stocks to smoke."
Public Campaigns and Sanctions
Additionally, the FTC alleges that Shkreli organized public campaigns to short pharmaceutical stocks based on predictions of failed clinical trials. The court filing demands that Shkreli be held in civil contempt and face sanctions, which may include:
- A complete accounting of his pharmaceutical company stock trades
- Divestment of any ownership in pharmaceutical companies
- A monetary fine equal to his profits from these violations
- Escalating consequences for future violations, including additional fines and possible incarceration
